| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
90,000,000 |
| Market
Cap: |
1.70(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$18.88 - $18.88 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hassler Randal |
EVP, Pharmaceutical Ops. |
• – – |
2019-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,172 |
7,172 |
|
- |
|
| Benedict Larry |
EVP and PAO |
• – – |
2019-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,055 |
41,462 |
|
- |
|
| Lavelle Erin |
Chief Operating Officer |
• – – |
2019-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
5,842 |
5,842 |
|
- |
|
| Bucher James B |
EVP & General Counsel |
• – – |
2019-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,810 |
11,706 |
|
- |
|
| Green Jeremy |
10% Owner |
– – • |
2019-03-04 |
4 |
A |
$11.50 |
$19,999,995 |
I/I |
1,739,130 |
8,244,896 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-12-03 |
4 |
AS |
$13.84 |
$69,826 |
D/D |
(5,044) |
831 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-12-03 |
4 |
OE |
$0.99 |
$4,994 |
D/D |
5,044 |
5,875 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2018-11-30 |
4 |
A |
$9.35 |
$4,553 |
D/D |
487 |
244,180 |
|
- |
|
| Benedict Larry |
EVP and PAO |
• – – |
2018-11-30 |
4 |
A |
$9.35 |
$8,920 |
D/D |
954 |
34,407 |
|
- |
|
| Bucher James B |
EVP & General Counsel |
• – – |
2018-11-30 |
4 |
A |
$9.35 |
$2,553 |
D/D |
273 |
3,896 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-11-01 |
4 |
AS |
$13.42 |
$67,637 |
D/D |
(5,040) |
831 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-11-01 |
4 |
OE |
$0.99 |
$4,990 |
D/D |
5,040 |
5,871 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2018-11-01 |
4 |
AS |
$13.40 |
$335,589 |
D/D |
(25,002) |
243,693 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2018-11-01 |
4 |
OE |
$6.77 |
$227,954 |
D/D |
25,002 |
268,695 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2018-10-01 |
4 |
AS |
$15.25 |
$386,006 |
D/D |
(24,999) |
243,693 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2018-10-01 |
4 |
OE |
$3.47 |
$109,108 |
D/D |
24,999 |
268,692 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-10-01 |
4 |
AS |
$15.26 |
$78,329 |
D/D |
(5,040) |
831 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-10-01 |
4 |
OE |
$0.99 |
$4,990 |
D/D |
5,040 |
5,871 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2018-09-04 |
4 |
AS |
$17.99 |
$449,680 |
D/D |
(24,999) |
243,693 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2018-09-04 |
4 |
OE |
$3.47 |
$86,622 |
D/D |
24,999 |
268,692 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-09-04 |
4 |
AS |
$18.00 |
$90,699 |
D/D |
(5,040) |
831 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-09-04 |
4 |
OE |
$0.99 |
$4,990 |
D/D |
5,040 |
5,871 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-08-01 |
4 |
AS |
$19.49 |
$98,489 |
D/D |
(5,040) |
831 |
|
- |
|
| Smith Jeffrey T L |
Managing Director |
• – – |
2018-08-01 |
4 |
OE |
$0.99 |
$4,990 |
D/D |
5,040 |
5,871 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2018-08-01 |
4 |
AS |
$19.55 |
$488,768 |
D/D |
(24,999) |
243,693 |
|
- |
|
296 Records found
|
|
Page 2 of 12 |
|
|
